Generics 133

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Hyoscine butylbromide manufacturers

133 products found

Filters

133 products found

hyoscine butylbromide

Ampoules, injection 20 mg/1 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

hyoscine butylbromide + paracetamol

Tablets, film coated 10 mg + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
OTC
Manufacturer #958
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, LATAM, Africa, and Asia for 10+ years. Key production lines are Rx, OTC, and medical devices. Main therapeutic areas include oncology, CNS, and respiratory.

Manufacturer usually replies in 8 days

hyoscine butylbromide + metamizole sodium monohydrate

Tablets, film coated 10mg+250mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16168
It focuses on manufacturing drugs from herbal source materials. They are one of Europe's largest herbal medicine manufacturers. They have been introducing contemporary herbal remedies to the market for over 75 years, integrating natural medicine successes with the most cutting-edge medication production methods.

Manufacturer usually replies in 19 days

hyoscine butylbromide

Suppositories 10mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16168
It focuses on manufacturing drugs from herbal source materials. They are one of Europe's largest herbal medicine manufacturers. They have been introducing contemporary herbal remedies to the market for over 75 years, integrating natural medicine successes with the most cutting-edge medication production methods.

Manufacturer usually replies in 19 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30077

Manufacturer usually replies in nan days

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP
Manufacturer #20853
The company’s mission is to invest in and operate businesses that restore health and enhances the lives of those they serve. Healthcare professionals use medicines and diagnostic devices to treat and manage infections, cardiovascular, metabolic, gastroenterological, rheumatic conditions, and more.

Manufacturer usually replies in 4 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP, PICS
Manufacturer #20652
It is a leading EU GMP-certified pharmaceutical company. It is focused on developing, manufacturing, and marketing branded off-patent pharmaceuticals, medical devices, and consumer healthcare products. The products are exported to countries in Asia Pacific, Africa, and the Middle East. Presence in over 22 countries. They have an experience of more than 50 years of in Southeast Asia.

Manufacturer usually replies in 5 days

hyoscine butylbromide

Solution for injection 20 mg/ml - 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Unavailable markets
Kosovo
Registered in
Kosovo
Manufacturer #2303

Manufacturer usually replies in 6 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

hyoscine butylbromide

Ampoules, injection 20 mg/ml - 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

hyoscine butylbromide

Injection 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Registered in
Myanmar
Manufacturer #19540

Manufacturer usually replies in 4 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19698

Manufacturer usually replies in 3 days

hyoscine butylbromide + paracetamol

Tablets 10 mg+500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472

Manufacturer usually replies in 4 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472

Manufacturer usually replies in 4 days

hyoscine butylbromide + paracetamol

Tablets 10 mg+500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19223

Manufacturer usually replies in 4 days

hyoscine butylbromide

Injection 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19154

Manufacturer usually replies in 2 days

hyoscine butylbromide + paracetamol

Tablets 10mg+500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ecuador
GMP approvals
WHO
Manufacturer #18729
The company is focused to develop, manufacture and market high-quality pharmaceutical products, satisfying the needs of customers, and doctors and improving the quality of life of patients, supported by the high professional level of our human and technological resources, under strict quality controls and oriented to the preservation of the environment.

Manufacturer usually replies in 4 days

hyoscine butylbromide

Tablets, film coated 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #18590
The company is focused on assurance of the best quality, the search for innovative manufacturing processes, and the permanent commitment to scientific research. The development of each of the production and administrative processes are guided by the philosophy of productivity and effectiveness to achieve the satisfaction of the customers, for which the company has world-class technological models.

Manufacturer usually replies in 1 days

hyoscine butylbromide

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18130

Manufacturer usually replies in 4 days

Want to view all 133 products? Create your free account today!

Hyoscine butylbromide

Hyoscine butylbromide, also called scopolamine butylbromide is a medication used in the treatment of Crampy abdominal pain, bladder & esophageal spasms & renal colic. It especially eases the bloating and the spasm-type pain associated with irritable bowel syndrome and diverticular disease. Its actions relax muscles in gastrointestinal and urinary systems. Hyoscine butylbromide also improves respiratory secretions at the end of life. It is also effective in decreasing the duration of the first stage of labor, while not being associated with any obvious adverse outcomes in mother or newborn. HB improves the quality of pictures during abdominal or pelvic MRI or CT. It can also help bladder cramps and period pain. Its medicine form is manufactured from Hyoscine, which occurs naturally in the plant deadly nightshade. Hyoscine butylbromide is sold under the brand name Buscopan among others. Hyoscine butylbromide has not received approved for sales in the United States, but a similar compound, Methscopolamine is used instead. In Europe, the Manufacturer and Licence Holder is Istituto De Angeli S.r.I, Loc. Prulli in Italy and procured from within the EU. The Licence Holder is LTT Pharma Limited from the UK. Forms and Dosage Hyoscine butylbromide is taken orally or given as an injection into a muscle, or into a vein, as a 20 mg in 1 ml ampoule for Intra Muscular or slow Intra Venous injection. In the treatment of MR enterography, the standard prescribed dose is 0.3 mg/kg IV with a maximum dose capped at 20 mg. in the treatment of Acute spasms, the oral medicine for children in the age group of 6-12 yrs old is 10 mg/dose and for 12-18 yrs old: 20 mg/dose. As an injection for either the muscle or nerves, the recommended dosage for children age 2-6 yrs old is 5 mg per dose with max capped at 15 mg per day. For children aged 6-12 years old it is 5-10 mg per dose with max capped at 30 mg per day and for teenagers, in the age group of 12-18 yrs old, the prescribed dose is 20 mg per dose, with max capped at 80 mg/day. For Adults, the standard recommended dose is 10-20 mg per dose up to 3-5 times a day with the maximum capped at 100 mg per day.

The cost of Hyoscine butylbromide

In the developing countries in India, a 2 weeks supply of tablet costs the consumer as low as USD2.3, whereas the injection cost USD1.5. in Australia, 5 ampoules of 20 mg injections cost AUD23.

How does Hyoscine butylbromide work?

Hyoscine butylbromide quaternary ammonium compound as well as a semisynthetic derivative of Scopolamine. As an Antimuscarinic, it binds to muscarinic acetylcholine receptors, blocking their effect. The attachment of the butyl-bromide moiety minimizes undesirable central nervous system side effects associated with scopolamine/Hyoscine, thereby effectively preventing the movement of this drug across the blood-brain barrier. It decreases the stimulation in smooth muscle contractions and the production of respiratory secretions.

Finding Hyoscine butylbromide Manufacturers and Suppliers:

The process of finding trusted Hyoscine butylbromide manufacturers and Hyoscine butylbromide suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Hyoscine butylbromide. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.